SCHEMBL7168136

SCHEMBL7168136

CCC(=CO)OCc1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.50
HCAR2 Q8TDS4 1/20 0.44
L3MBTL1 Q9Y468 3/20 0.44
TDP1 Q9NUW8 3/20 0.44
KMT2A Q03164 2/20 0.44
MAPK1 P28482 2/20 0.44
SLC6A2 P23975 2/20 0.44
SLC6A3 Q01959 2/20 0.44
CA12 O43570 2/20 0.44
CA9 Q16790 2/20 0.44
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
LMNA P02545 3/20 0.42
RAB9A P51151 2/20 0.42
GAA P10253 1/20 0.42
TSHR P16473 2/20 0.41
CYP3A4 P08684 1/20 0.41
CYP1A2 P05177 1/20 0.41
PTGS1 P23219 1/20 0.41
CYP2C19 P33261 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7168135 1.00 ALDH1A1 (0.50) ALDH1A1HCAR2L3MBTL1TDP1KMT2A
SCHEMBL19143851 0.86 ALDH1A1 (0.52) ALDH1A1HCAR2L3MBTL1TDP1KMT2A
SCHEMBL20006789 0.83 ALDH1A1 (0.48) ALDH1A1HCAR2L3MBTL1TDP1KMT2A
SCHEMBL22297645 0.81 ALDH1A1 (0.47) ALDH1A1HCAR2L3MBTL1TDP1KMT2A
SCHEMBL19710611 0.81 ALDH1A1 (0.47) ALDH1A1HCAR2L3MBTL1TDP1KMT2A
SCHEMBL21697571 0.80 ALDH1A1 (0.46) ALDH1A1HCAR2L3MBTL1TDP1KMT2A
SCHEMBL19650394 0.79 ALDH1A1 (0.44) ALDH1A1HCAR2L3MBTL1TDP1KMT2A
SCHEMBL20801933 0.78 ALDH1A1 (0.43) ALDH1A1HCAR2L3MBTL1TDP1KMT2A
SCHEMBL11687114 0.75 ALDH1A1 (0.57) ALDH1A1HCAR2L3MBTL1TDP1KMT2A
SCHEMBL23241725 0.75 RCE1 (0.50) ALDH1A1HCAR2L3MBTL1TDP1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6559347-B2 As dienophiles with dienes such as cyclopentadiene and cyclohexadiene, at an elevated pressure WAKE FOREST UNIVERSITY HEALTH SCIENCES 2003-05-06 US disclosed
US-20020173668-A1 Diels-alder adducts of epoxybutene and epoxybutene derivatives WAKE FOREST UNIVERSITY 2002-11-21 US disclosed
US-6380447-B1 PRESSURIZATION; FORMING BICYCLIC COMPOUNDS WAKE FOREST UNIVERSITY 2002-04-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020173668-A1 Diels-alder adducts of epoxybutene and epoxybutene derivatives DERA, CYP11B1, SQLE ALDH1A1 19/4885HCAR2 4227/4885L3MBTL1 1443/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.